AcelRx Pharmaceuticals Stock News

Aziyo Biologics, Inc. (AZYO) delivered earnings and revenue surprises of -28.13% and 2.29%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stoc

HAYWARD, Calif., March 3, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release fourth quarter financial results after market close on Thursday, March 10, 2022. AcelRx management will host a live webcast…

AcelRx Pharmaceuticals (ACRX) announced real-world data for sufentanil sublingual tablet ((SST)) for pain management in patients undergoing awake plastic surgery showing a rapid…

DSUVIA sales continue to lag expectations. Visibility of earnings and net cash further reduced by Lowell acquisition which is hard to assess at this stage.

AcelRx continues to be an abysmal investment as the company's flagship product DSUVIA has struggled to gain traction in the middle of COVID-19 headwinds. The lack of DoD orders are hurting the company

Are these penny stocks on your January 2022 watchlist? The post Best Penny Stocks to Buy In January 2022? 3 Investors Are Watching appeared first on Penny Stocks to Buy, Picks, News and Information |

Penny stocks with hight hopes from analysts. The post Top Penny Stocks To Buy According To Analysts & Targets Up To 615% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock

Are these penny stocks on your January 2022 watchlist? The post Best Penny Stocks to Buy In January 2022?

Penny stocks with hight hopes from analysts. The post Top Penny Stocks To Buy According To Analysts & Targets Up To 615% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) with the stream of -3.03% also noticed, India AbbVie Inc. (NYSE:ABBV) encountered a rapid change of 0.62% in the last hour of Tuesdays trading session. AcelRx The post Volume Buzz: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), AbbVie Inc. (NYSE:ABBV) appeared first on Stocks Equity .

Goldman Sachs Group Inc. decreased its stake in shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) by 45.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 107,938 shares of the specialty pharmaceutical companys stock after selling 91,266 shares during the period. Goldman Sachs Group Inc.s holdings in []

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) with the stream of -2.17% also noticed, India New Gold Inc. (AMEX:NGD) encountered a rapid change of -2.76% in the last hour of Fridays trading session. The post Bright Stock Buzz: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), New Gold Inc. (AMEX:NGD) appeared first on Stocks Equity .

Vonage Holdings Corp. (VG) with the stream of 0.58% also noticed, India AcelRx Pharmaceuticals, Inc. (ACRX) encountered a rapid change of -5.81% in the last hour of Fridays trading session. The post Blustering Stock: Vonage Holdings Corp. (NASDAQ:VG), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) appeared first on Stocks Equity .

Millennium Management LLC boosted its stake in AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) by 21.9% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,516,715 shares of the specialty pharmaceutical companys stock after buying an additional 272,974 shares during the quarter. Millennium Management []